Italy To Consult On Pricing Transparency Requirements
Transparency Requirements Could Be Taken Up In Other EU Countries
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
You may also be interested in...
Following on from moves to push price transparency on to the global agenda, Italy is poised to pass a decree that would oblige companies to disclose public R&D funding.
A draft decree in Italy aims to put added therapeutic value at the centre of reimbursement decisions.
EU countries should use a milestone World Health Organization resolution calling for more transparency on net medicine prices to help secure better access to medicine, says the Valletta group.